Big news today as the American Society of Hematology meeting kicks - TopicsExpress



          

Big news today as the American Society of Hematology meeting kicks off: Jakafi yesterday became the first FDA approved treatment for Polycythemia Vera patients who cannot tolerate Hydroxyurea. This marks the second indication for use of Jakafi in the MPN, following its approva in 2011l for symptom relief in myelofibrosis. smpnresearchfoundation.org/Jakafi-approved-for-uncontrolled-polycythemia-vera
Posted on: Fri, 05 Dec 2014 17:23:40 +0000

Trending Topics



Recently Viewed Topics




© 2015